Project Grant HT94252410139
- Federal Grant Award Summary Georgetown University received a $780,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 15, 2025, with an ultimate completion date of June 14, 2028. The award supports research investigating environmentally induced sperm ribonucleic acids (RNAs) as mediators of placentation, progeny, and maternal health. This three-year research initiative will be conducted at Georgetown...
- The U.S. Defense Health Agency awarded a $624,000 Project Grant to Georgetown University under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING OVARIAN STROMAL CELL SENESCENCE TO MITIGATE IR-INDUCED TRANSGENERATIONAL GASTROINTESTINAL CANCER RISK." The grant, with a performance period from July 1, 2024 to June 30, 2026, will support Georgetown's scientific investigation into developing treatments to address the increased risk of...
- The Washington University received a $236,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant funding supports research from July 1, 2021 to June 30, 2023 to study the role of blood-brain barrier dysfunction in epilepsy associated with tuberous sclerosis complex. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
- The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
- The Department of the Army Medical Command awarded Thomas Jefferson University a $841,473 project grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2026 to develop occult colorectal cancer elimination through GUCY2C-directed immunotherapy. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
- The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
- This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
- The Department of the Army Medical Command awarded Rutgers, The State University of New Jersey a $751,587 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research targeting adenosine kinase for the prevention of post-traumatic epilepsy from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health...
- The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
Georgetown University received a $971,537 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research to target cellular senescence and prevent post-traumatic epilepsy. The project will be conducted at Georgetown's facility in Washington, D.C. and is scheduled for completion by March 31, 2027. The Military Medical Research and Development program funds a range of biomedical research to improve the health and care of military service members, veterans, and their families, with a focus on innovative, high-impact projects. This grant aligns with the program's objectives to develop new treatments, diagnostic tools, and clinical practice guidelines relevant to military medicine.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $971.5k | 2/8/24 |